Press Releases and Statements

The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.

The 2019 results from the NIDA and University of Michigan’s annual drug abuse survey, Monitoring the Future, show that the number of teens using OTC cough medicine containing DXM to get high decreased slightly.

CHPA congratulates Dr. Hahn on his confirmation today as the 24th Commissioner of the U.S. Food and Drug Administration. Commissioner Hahn’s experience as a practicing oncologist, researcher, and former chief medical officer of the MD Anderson Cancer Center make him well-suited to his new role.

CHPA today announced that Beth Allgaier has been named Senior Vice President, Business Development and Industry Relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community.

CHPA today applauds the U.S. Food and Drug Administration for enforcing existing provisions in the Federal Food, Drug, and Cosmetic Act by sending warning letters to 15 companies illegally marketing cannabidiol products.

At its fall meeting, CHPA leadership approved Amardeep Kahlon, Chief Marketing Officer and Vice President of U.S. Marketing at GSK Consumer Healthcare to serve as the new chair of the CHPA Educational Foundation’s board of directors.

At CHPA’s fall meeting, the Board of Directors elected Barry Reichgott, General Manager, Colgate Oral Pharmaceuticals, Colgate-Palmolive Company, as its newest member. In June, Dan Quail, president, North America, Similasan USA was approved to serve on the board.

Michigan Governor Gretchen Whitmer today signed HB 4412, legislation to combat teen abuse of OTC medicines containing the cough suppressant dextromethorphan (DXM).

Today CHPA submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol in dietary supplements. 

Through several CHPA member company donations, 144 U.S. schools of pharmacy received over 100 different OTC medicines, medical devices, and dietary supplements to educate and prepare future pharmacists.

CHPA supports and encourages continued research and promotes ongoing consumer education to help ensure safe use of OTC medicines.